28 October 2020
Freemasons New Zealand have renewed their support of the Institute’s CAR T-cell programme, pledging a further $600,000 over the next three years.

The CAR T-cell team with Freemasons New Zealand
Freemasons New Zealand Grand Master Graham Wrigley says Freemasons New Zealand are proud to continue to support the Institute’s work because it is practical research that will have real outcomes that have the potential to improve the lives of all New Zealanders.
“Freemasons New Zealand donate extensively to medical research programmes like this CAR T-cell research because they are a promising and effective way that we can do something tangible to help New Zealanders. Our support is motivated by the guiding principles that underpin Freemasonry, particularly compassion and love of, and support for, humankind.”
Director of the Malaghan Institute professor Graham Le Gros says the financial partnership with the Freemasons provides a significant and vital boost to the Institute’s CAR T-cell research.
“As an independent research organisation and charity, the Malaghan Institute relies on support from the community and the generosity of organisations like Freemasons whose support, along with that of other organisations, will allow us to accelerate the availability of this ground-breaking treatment in New Zealand.”
Related articles

Horizontal mitochondria transfer: 10 years on from a groundbreaking discovery
7 May 2025

Kjesten Wiig: bringing life-changing treatments to life
27 February 2025

Malaghan CAR T-cell cancer therapy trial expands to Christchurch and Auckland
24 February 2025

Cancer Research Trust grant to improve CAR T-cell therapy
12 February 2025

World-renowned cancer pathologist joins the Malaghan Institute as Distinguished Research Fellow
19 December 2024

Community partnerships: Zephyr Consulting empowering emerging scientific talent
18 November 2024